WO2012073892A1 - Method for evaluating texture using oxytalan fibers as index - Google Patents

Method for evaluating texture using oxytalan fibers as index Download PDF

Info

Publication number
WO2012073892A1
WO2012073892A1 PCT/JP2011/077397 JP2011077397W WO2012073892A1 WO 2012073892 A1 WO2012073892 A1 WO 2012073892A1 JP 2011077397 W JP2011077397 W JP 2011077397W WO 2012073892 A1 WO2012073892 A1 WO 2012073892A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
texture
oxytalan
total
fiber length
Prior art date
Application number
PCT/JP2011/077397
Other languages
French (fr)
Japanese (ja)
Inventor
青木 宏文
美郷 豊田
勝田 雄治
茂 麦倉
Original Assignee
株式会社資生堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社資生堂 filed Critical 株式会社資生堂
Publication of WO2012073892A1 publication Critical patent/WO2012073892A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates

Definitions

  • the present invention relates to a method for measuring the fineness of skin texture using oxytalan fibers as an index.
  • the present invention further relates to a method for improving skin texture by increasing oxytalan fibers, and a method for screening a skin texture improving agent using oxytalan fibers as an index.
  • the texture composed of skin grooves and cuticles on the skin surface causes light scattering on the skin surface and is involved in the youthfulness and beauty of the skin.
  • infants' skin has many fine textures, giving them a smooth and transparent feeling that is unique to infants.
  • the small texture disappears and the texture becomes larger, and the skin groove flows and the directionality is increased. It will cause wrinkles and fine wrinkles.
  • the skin texture evaluation methods known so far are based on external measurement of the surface condition of the skin, but the texture is evaluated histologically and physiologically from the inside of the skin. The method has not yet been developed.
  • the problems to be solved by the present invention are to establish a method for histologically and physiologically evaluating skin texture, and to improve and improve the skin texture by using a physiological evaluation method for skin texture. It is to provide a drug screening method and to provide a skin texture improving method based on the histological and physiological knowledge of the texture obtained by the present invention.
  • the present inventors have found that many oxytalan fibers running vertically to the epidermis are present inside the cuticle part, but are present inside the skin groove part. I found that I did not. Based on this discovery, the present inventors have found that the rise of the dermis is caused by oxytalan fibers running longitudinally in the epithelium, and oxytalan fibers are involved in the formation of the texture composed of the dermis and skin groove. I hypothesized that.
  • the total oxytalan fiber length per unit length inside the dermis of the skin section was measured and compared with the dermis density grade defined as an indicator of the fineness of the dermis. It was surprisingly found that there is a high correlation between a decrease in density grade and a decrease in the fiber length. In other words, it is considered that the decrease in the total oxytalan fiber length inside the skin mound, the decrease in fineness of the texture, and the deterioration of the shape are deeply involved.
  • a texture evaluation method was established by measuring the total oxytalan fiber length per unit length of the skin section. Furthermore, the texture evaluation method further includes a step of comparing the measured total oxytalan fiber length with an index for the average total oxytalan length in each dendrite density grade. Furthermore, as described above, the present inventors have clarified the structure of the texture from the histological and / or physiological aspects, so that the total oxytalan fiber length per unit skin section before and after the administration of the candidate drug.
  • the present invention provides a method for screening a skin texture-improving drug by measuring, and a method for improving skin texture by administering a drug that increases oxytalan fibers.
  • the present invention provides a method for evaluating the texture histologically and physiologically.
  • the present invention provides histological and physiological knowledge about the formation of the texture, and enables screening of drugs by focusing on the increase in oxytalan fibers in the texture improving drug and the texture improving method.
  • FIG. 1 is a diagram showing a hide density density grade.
  • FIG. 2 is a skin section of a 35 year old adult stained with Elastica Wangison (Weigert) stain.
  • FIG. 3 is a skin section of a 66 year old adult stained with Elastica Wangyson (Weigert) stain.
  • FIG. 4 is a diagram in which oxytalan fibers are identified and traced in a skin section of a subject stained with Elastica Wangison (Weigert) staining.
  • FIG. 5 is a graph plotting the total oxytalan fiber length against the skin density grade, and the Pearson correlation coefficient is 0.54.
  • the present invention relates to a skin texture evaluation method by measuring the total oxytalan fiber length per unit length of a skin section. More specifically, the present invention relates to a skin texture evaluation method by measuring the total oxytalan fiber length per arbitrary length (for example, 1 mm, 2 mm, 0.5 cm, 1 cm, 2 cm, 5 cm, etc.) of a skin section. .
  • the present inventors have shown that the total oxytalan fiber length per unit length directly under the skin epidermis correlates with the dermis density grade, and by measuring the total oxytalan fiber length per unit length of the skin section, Can evaluate skin texture.
  • the texture of the skin is evaluated by comparing the total oxytalan fiber length per unit length of the target with the total oxytalan fiber length per unit length as an index.
  • This index can be created from a graph obtained by plotting the total oxytalan fiber length per unit length against the skin density density of the subject group. Since bark density grades 1-2, 2-3, and 3-4 are judged as poor, normal, and good, respectively, the total oxytalan fiber length corresponding to bark density grades 2 and 3 is used as an index. It can be.
  • the total oxytalan fiber length corresponding to an arbitrary point such as a skin density grade 1.5, 2.5, and 3.5 can also be used as an index.
  • any total oxytalan fiber length per unit length can be used as an index.
  • 500 ⁇ m, 1000 ⁇ m, 1500 ⁇ m, 2000 ⁇ m, 2500 ⁇ m, or 3000 ⁇ m can be selected as an index per 1 mm of skin length.
  • the skin by comparing the total oxytalan fiber length per unit length measured with the total oxytalan fiber length per unit length in the skin of the same subject, the same or a corresponding site, measured in advance It is related with the texture evaluation method. In this case, it is possible to evaluate whether or not the use of a texture improving agent or a skin care product contributes to the improvement of the texture.
  • Another aspect of the present invention relates to a method for screening a skin texture improving agent by measuring the total oxytalan fiber length per unit length before and after administration of a candidate drug.
  • a method for screening a skin texture improving agent by measuring the total oxytalan fiber length per unit length before and after administration of a candidate drug.
  • the present invention also relates to a method for improving skin texture by increasing oxytalan fibers. Since the present inventors have discovered that oxytalan fibers in the skin epidermis are involved in the formation of skin texture, it has been found that increasing oxytalan fibers is important for improving the texture. Therefore, the skin texture can be improved by administration of a drug that increases oxytalan fibers in the epithelium or skin care. The improvement of the texture can be done for cosmetic, therapeutic and preventive purposes. Examples of such skin care include, but are not limited to, massage and moisturizing.
  • the term “texture” refers to a surface form formed by a cuticle and a skin groove on the surface of skin.
  • the skin hill part constituting the texture is surrounded by a skin groove, and many take a triangular shape, but some take a polygonal shape.
  • a well-textured state refers to a state where the number of fine triangular cuticles and crevices that are well-formed is large, and the number and density of the crevice decreases with age as the crevice and cuticles become blurred. However, the length of the crevice tends to increase, and such a state is called a bad state.
  • the hide density density grade defined in this specification represents the fineness of the hide, the larger the hide density density grade, the better the texture (FIG. 1).
  • the present inventors have discovered that many oxytalan fibers running vertically to the epidermis are present inside the dermis, but not inside the sulcus, and the swell of the dermis is raised. It was concluded that is caused by oxytalan fibers running longitudinally in the epithelium. While dense and long oxytalan fibers are present in the cuticle part, and no oxytalan fibers are present in the skin groove part, the skin groove is deepened and the texture state is excellent.
  • the crevice becomes shallow, the boundary between the crevice and the cuticle becomes blurred, and the texture deteriorates. Therefore, it is possible to evaluate the texture state by measuring the fiber length of oxytalan per unit length.
  • any site can be used as the site of the skin for measuring the total oxytalan fiber length per unit length, but the skin of the face such as the cheeks and the forehead, the back of the hand, and the skin of the hand are particularly preferable.
  • a slice of arm skin is used.
  • a surplus skin fragment obtained by diet surgery can also be used.
  • the total oxytalan fiber length per unit length is measured for the abdominal skin.
  • Measurement of the total oxytalan fiber length per unit length of the skin section is performed after the skin section is stained so that the oxytalan fiber can be identified.
  • the skin section may be stained by any method as long as oxytalan fibers can be identified. For example, Elastica Wangyson (Weigert) staining, which can stain elastic fibers, is performed, and oxytalan fibers are stained purple-black with Weigert's solution.
  • the oxytalan fibers run perpendicular to the epidermis surface, and a large amount exists particularly in the cuticle (FIGS. 2 and 3).
  • the stained image of the skin section is captured with a CCD camera, the oxytalan fibers are traced with computer software (Win Roof), and the total trace length per 1 mm of the epidermis is summed to measure the total oxytalan fiber length per unit length of the epidermis. be able to.
  • “Oxytalan fiber” is a fiber component that creates mechanical strength in the connective tissue of a living body, and is one of elastic fibers. Elastic fibers are particularly abundant in organs and tissues subjected to mechanical pressure, such as skin, blood vessels, lungs, and ligaments. Elastic fibers are composed of elastin and microfibril protein, and are classified into three types according to the composition ratio of elastin: elastic fiber, elaurin fiber, and oxytalan fiber. Among these, oxytalan fibers are those in which the content of elastin fibers is low and the microfibril protein forms a dense bundle. In tissues, it has been reported that they exist as periodontal ligaments that support teeth and as fibers directly under the epidermis that run perpendicular to the epidermis surface in the skin (Non-patent Document 2).
  • “Dune density grade” is an indicator of the fineness of the hide.
  • the texture is divided into four groups: bad, slightly bad, normal, and good, and representative images of each are listed in FIG.
  • the hill density grade in the subject's skin can be determined.
  • several experienced researchers familiar with the enlarged image of the texture compare the texture image group to be evaluated with this dendrite density grade, and have the fineness of the nearest dend.
  • the grade number that can be felt is selected for each texture image.
  • attributes such as age of the subject of each texture image are completely hidden by both the evaluation researcher and the test management researcher, so that a double blind test is performed.
  • the skin density grade of the texture image is obtained. Since the skin condition and the dermis density grade are closely related, if it is judged that it falls under the hill density grade 1-2, it is judged that the skin condition is bad and falls within the hill density grade 2-3. If it is determined that the texture state is normal, and it is determined that it corresponds to the hill density grade 3 to 4, it can be determined that the texture state is good.
  • administration includes, but is not limited to, transdermal administration, oral administration, intradermal administration, subcutaneous administration, intramuscular administration, intravenous administration, intraperitoneal administration, and the like. It is not a thing.
  • the medicament is administered by transdermal administration, subcutaneous administration, or intradermal administration.
  • the texture image in Fig. 1 is defined as skin mound density grade 1 to 4 respectively, and four skilled researchers familiar with the enlarged texture image are the texture images to be evaluated.
  • the group was compared with the image of FIG. 1, and a grade number that was visually felt as having the fineness of the nearest skin was selected for each texture image.
  • the attributes such as age of the subject of each texture image are hidden by both the evaluation researcher and the test management researcher to make a double blind test, and the skins from multiple researchers obtained for each texture image By calculating the average value of the density grades, it was set as the hill density grade of the texture image.
  • Table 1 below shows the relationship between the bark density grade thus obtained and the total oxytalan fiber length per unit length.
  • FIG. 5 was obtained by plotting the total oxytalan fiber length per unit length against the bark density grade. Pearson's correlation coefficient was 0.54, indicating a correlation between the dermis density grade and the total oxytalan fiber length per unit length.
  • the skin density grade is an index of the fineness of the skin, and since it has a close relationship with the texture, the texture can be evaluated using the oxytalan fibers of the skin as an index.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Cosmetics (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The purpose of the present invention is to establish a physiologically based method for evaluating the texture of skin, provide a method for screening a skin texture improvement method/improvement drug which uses a method for physiologically evaluating the texture of skin, and provide a method for improving the texture of skin on the basis of physiological findings relating to texture, obtained by the present invention. By the present invention, the total oxytalan fiber length per unit length of a skin section is measured. The total oxytalan fiber length in the skin section serves as an index for the texture of the skin.

Description

オキシタラン線維を指標とした肌理評価法Skin texture evaluation method using oxytalan fiber as an index
 本発明は、オキシタラン線維を指標とした皮膚の肌理(キメ)の細かさを測定する方法に関する。さらに本発明は、オキシタラン線維を増加させることによる皮膚の肌理改善方法、並びにオキシタラン線維を指標とした皮膚の肌理改善薬のスクリーニング方法にも関する。 The present invention relates to a method for measuring the fineness of skin texture using oxytalan fibers as an index. The present invention further relates to a method for improving skin texture by increasing oxytalan fibers, and a method for screening a skin texture improving agent using oxytalan fibers as an index.
 皮膚表面の皮溝と皮丘により構成される肌理は、皮膚表面上での光の散乱をもたらし、肌の若々しさや美しさに関与する。一般に乳幼児の皮膚には、細かい多数の肌理があり、乳幼児特有のすべすべ感や透明感を与えるが、年齢と供に小さな肌理が消失して肌理が大きくなり、また皮溝が流れて方向性が出ることによりシワや小ジワが生じる原因となる。 The texture composed of skin grooves and cuticles on the skin surface causes light scattering on the skin surface and is involved in the youthfulness and beauty of the skin. In general, infants' skin has many fine textures, giving them a smooth and transparent feeling that is unique to infants. However, with the age, the small texture disappears and the texture becomes larger, and the skin groove flows and the directionality is increased. It will cause wrinkles and fine wrinkles.
 したがって、皮膚の肌理を保つことは美容上特に有用であり、さらに肌理を測定し、評価することは美容上、並びに美容に関わる商品の研究開発やサービス提供において重要である。これまでのところ、皮膚の表面を顕微鏡などで撮影し、皮溝や皮丘について情報処理を行うことにより肌理の状態を評価する方法(特許文献1)や、レプリカ法を用いて皮膚の肌理状態を評価する方法(特許文献2)、さらには音響システムを用いた皮膚の肌理の評価方法(特許文献3)などが開発されている。 Therefore, maintaining the texture of the skin is particularly useful in cosmetics, and measuring and evaluating the texture is important in cosmetics and in the research and development of products related to beauty and the provision of services. So far, the method of evaluating the skin condition by photographing the surface of the skin with a microscope and performing information processing on the skin groove and the cuticle (Patent Document 1), and the skin condition using the replica method A method for evaluating skin (Patent Document 2) and a skin texture evaluation method using an acoustic system (Patent Document 3) have been developed.
 しかしながら、これまで知られている肌理の評価方法は、皮膚の表面状態を外部から計測することに基づき肌理を評価するものであるが、皮膚の内側から組織学的・生理学的に肌理を評価する方法は未だ開発されていなかった。 However, the skin texture evaluation methods known so far are based on external measurement of the surface condition of the skin, but the texture is evaluated histologically and physiologically from the inside of the skin. The method has not yet been developed.
特開2006-305184号公報JP 2006-305184 A 特開2001-170028号公報Japanese Patent Laid-Open No. 2001-170028 特開2008-114067号公報JP 2008-114067 A
 そこで、本発明が解決すべき課題は、皮膚の肌理を組織学的及び生理学的に評価する方法を確立すること、並びに皮膚の肌理の生理学的評価方法を用いることによる皮膚の肌理改善法・改善薬のスクリーニング方法を提供すること、並びに本発明により得られた肌理の組織学的及び生理学的知見に基づき、皮膚の肌理改善方法を提供することである。 Therefore, the problems to be solved by the present invention are to establish a method for histologically and physiologically evaluating skin texture, and to improve and improve the skin texture by using a physiological evaluation method for skin texture. It is to provide a drug screening method and to provide a skin texture improving method based on the histological and physiological knowledge of the texture obtained by the present invention.
 本発明者らが、上記課題の解決を目的として鋭意検討を行った結果、表皮に対して縦に走るオキシタラン線維が皮丘部の内側に多く存在する一方で、皮溝部の内部には存在していないということを発見した。この発見に基づき、本発明者らは、皮丘部の盛り上りが上皮内で縦に走るオキシタラン線維によりもたらされ、皮丘と皮溝により構成される肌理の形成に、オキシタラン線維が関与しているという仮説を立てた。この仮説についてさらに検証した結果、皮膚切片の皮丘部内部の単位長さあたりの延べオキシタラン線維長を計測し、皮丘の細かさの指標として定義した皮丘密度グレードと比較したところ、皮丘密度グレードの低下と当該線維長の減少に高い相関性を有することを驚くべきことに発見した。つまり、皮丘部の内部の延べオキシタラン線維長の減少と、肌理の細かさの減少や形状の劣化が深く関与すると考えられる。 As a result of intensive studies aimed at solving the above-mentioned problems, the present inventors have found that many oxytalan fibers running vertically to the epidermis are present inside the cuticle part, but are present inside the skin groove part. I found that I did not. Based on this discovery, the present inventors have found that the rise of the dermis is caused by oxytalan fibers running longitudinally in the epithelium, and oxytalan fibers are involved in the formation of the texture composed of the dermis and skin groove. I hypothesized that. As a result of further verification of this hypothesis, the total oxytalan fiber length per unit length inside the dermis of the skin section was measured and compared with the dermis density grade defined as an indicator of the fineness of the dermis. It was surprisingly found that there is a high correlation between a decrease in density grade and a decrease in the fiber length. In other words, it is considered that the decrease in the total oxytalan fiber length inside the skin mound, the decrease in fineness of the texture, and the deterioration of the shape are deeply involved.
 この発見に基づき、皮膚切片の単位長さあたりの延べオキシタラン線維長を計測することによる、肌理の評価方法を確立した。さらに、計測した延べオキシタラン線維長を各皮丘密度グレードにおける平均延べオキシタラン長についての指標と比較する工程をさらに含む上記肌理の評価方法を提供する。さらに、上記のように本願発明者らは、組織学的及び/又は生理学的な面から肌理の構造を明らかにしたことにより、候補薬剤の投与の前後における、単位皮膚切片あたりの延べオキシタラン線維長を計測することによる、皮膚の肌理改善薬のスクリーニング方法、さらにはオキシタラン線維を増加させる薬剤を投与することによる皮膚の肌理改善方法を提供する。 Based on this discovery, a texture evaluation method was established by measuring the total oxytalan fiber length per unit length of the skin section. Furthermore, the texture evaluation method further includes a step of comparing the measured total oxytalan fiber length with an index for the average total oxytalan length in each dendrite density grade. Furthermore, as described above, the present inventors have clarified the structure of the texture from the histological and / or physiological aspects, so that the total oxytalan fiber length per unit skin section before and after the administration of the candidate drug. The present invention provides a method for screening a skin texture-improving drug by measuring, and a method for improving skin texture by administering a drug that increases oxytalan fibers.
 従来は皮膚表面を測定することによる肌理の評価方法しか知られていなかったところ、本発明は、組織学的及び生理学的に肌理を評価する方法を提供するものであり、肌理の評価法に多面的なアプローチを提供する点で利点がある。さらに、本発明は、肌理の形成について組織学的・生理的な知見を与えるものであり、肌理改善薬や肌理改善方法において、オキシタラン線維の増加に着目して、薬剤のスクリーニングを可能にする点で利点がある。 Conventionally, only the evaluation method of the texture by measuring the skin surface has been known, and the present invention provides a method for evaluating the texture histologically and physiologically. There is an advantage in providing a holistic approach. Furthermore, the present invention provides histological and physiological knowledge about the formation of the texture, and enables screening of drugs by focusing on the increase in oxytalan fibers in the texture improving drug and the texture improving method. There are advantages.
図1は、皮丘密度グレードを表す図である。FIG. 1 is a diagram showing a hide density density grade. 図2は、エラスチカワンギーソン(ワイゲルト)染色で染色した35歳の成人の皮膚切片である。FIG. 2 is a skin section of a 35 year old adult stained with Elastica Wangison (Weigert) stain. 図3は、エラスチカワンギーソン(ワイゲルト)染色で染色した66歳の成人の皮膚切片である。FIG. 3 is a skin section of a 66 year old adult stained with Elastica Wangyson (Weigert) stain. 図4は、エラスチカワンギーソン(ワイゲルト)染色で染色した被験者の皮膚切片において、オキシタラン線維を同定し、トレースした図である。FIG. 4 is a diagram in which oxytalan fibers are identified and traced in a skin section of a subject stained with Elastica Wangison (Weigert) staining. 図5は、皮丘密度グレードに対して延べオキシタラン線維長をプロットした図であり、ピアソンの相関係数は0.54である。FIG. 5 is a graph plotting the total oxytalan fiber length against the skin density grade, and the Pearson correlation coefficient is 0.54.
 本発明は、皮膚切片の単位長さあたりの延べオキシタラン線維長を計測することによる皮膚の肌理評価方法に関する。より具体的に、本発明は、皮膚切片の任意の長さ(例えば1mm、2mm、0.5cm、1cm、2cm、5cmなど)あたりの延べオキシタラン線維長を計測することによる皮膚の肌理評価方法に関する。本発明者らにより、皮膚表皮直下の単位長さあたりの延べオキシタラン線維長が、皮丘密度グレードと相関することが示され、皮膚切片の単位長さあたりの延べオキシタラン線維長を計測することにより、皮膚の肌理を評価することができる。 The present invention relates to a skin texture evaluation method by measuring the total oxytalan fiber length per unit length of a skin section. More specifically, the present invention relates to a skin texture evaluation method by measuring the total oxytalan fiber length per arbitrary length (for example, 1 mm, 2 mm, 0.5 cm, 1 cm, 2 cm, 5 cm, etc.) of a skin section. . The present inventors have shown that the total oxytalan fiber length per unit length directly under the skin epidermis correlates with the dermis density grade, and by measuring the total oxytalan fiber length per unit length of the skin section, Can evaluate skin texture.
 本発明の1の態様では、対象の単位長さあたりの延べオキシタラン線維長を、指標となる単位長さあたりの延べオキシタラン線維長と比較することにより、皮膚の肌理が評価される。この指標は、被験者群の皮丘密度グレードに対して単位長さあたりの延べオキシタラン線維長をプロットすることにより得られたグラフから作成することができる。皮丘密度グレード1~2、2~3、そして3~4がそれぞれ、肌理状態が悪い、普通、及び良いと判定されるため、皮丘密度グレード2や3に対応する延べオキシタラン線維長を指標とすることができる。皮丘密度グレード1.5、2.5、及び3.5など任意の点に対応する延べオキシタラン線維長を指標とすることもできる。対象の単位長さあたりの延べオキシタラン線維長をこうしたグラフに当てはめることにより、対象の皮膚の肌理を評価することが可能となる。また、単位長さあたりの任意の延べオキシタラン線維長を指標とすることもでき、例えば皮膚の長さ1mmあたり、500μm、1000μm、1500μm、2000μm、2500μm、又は3000μmを指標として選択することができる。 In one aspect of the present invention, the texture of the skin is evaluated by comparing the total oxytalan fiber length per unit length of the target with the total oxytalan fiber length per unit length as an index. This index can be created from a graph obtained by plotting the total oxytalan fiber length per unit length against the skin density density of the subject group. Since bark density grades 1-2, 2-3, and 3-4 are judged as poor, normal, and good, respectively, the total oxytalan fiber length corresponding to bark density grades 2 and 3 is used as an index. It can be. The total oxytalan fiber length corresponding to an arbitrary point such as a skin density grade 1.5, 2.5, and 3.5 can also be used as an index. By applying the total oxytalan fiber length per unit length of the subject to such a graph, the texture of the subject's skin can be evaluated. In addition, any total oxytalan fiber length per unit length can be used as an index. For example, 500 μm, 1000 μm, 1500 μm, 2000 μm, 2500 μm, or 3000 μm can be selected as an index per 1 mm of skin length.
 本発明の別の態様では、計測した単位長さあたりの延べオキシタラン線維長を、前もって計測した同一対象、同一又は対応する部位の皮膚における単位長さあたりの延べオキシタラン線維長と比較することによる皮膚の肌理評価方法に関する。この場合、肌理改善剤やスキンケア用品などの使用が、肌理の改善に寄与しているか否かについて評価することができる。 In another aspect of the present invention, the skin by comparing the total oxytalan fiber length per unit length measured with the total oxytalan fiber length per unit length in the skin of the same subject, the same or a corresponding site, measured in advance It is related with the texture evaluation method. In this case, it is possible to evaluate whether or not the use of a texture improving agent or a skin care product contributes to the improvement of the texture.
 本発明の別の態様では、候補薬剤の投与の前後における単位長さあたりの延べオキシタラン線維長を計測することによる、皮膚の肌理改善薬のスクリーニング方法に関する。肌理の形成に関わるオキシタラン線維を測定することで、表皮を観察することによる肌理の評価方法より優れた感度で候補薬剤の皮膚の肌理改善効果についてスクリーニングをすることを可能にする。 Another aspect of the present invention relates to a method for screening a skin texture improving agent by measuring the total oxytalan fiber length per unit length before and after administration of a candidate drug. By measuring the oxytalan fibers involved in the formation of the texture, it is possible to screen the skin improvement effect of the candidate drug with a sensitivity superior to the evaluation method of the texture by observing the epidermis.
 本発明の更なる態様では、本発明は、オキシタラン線維を増加させることによる皮膚の肌理改善方法にも関する。本発明者らが、皮膚表皮におけるオキシタラン線維が皮膚の肌理の形成に関与するということを発見したため、肌理の改善にはオキシタラン線維を増加させることが重要であることが分かった。したがって、上皮においてオキシタラン線維を増加させる薬剤の投与やスキンケアにより、皮膚の肌理を改善することができる。肌理の改善は、美容学的、治療的、予防的な目的のために行うことができる。このようなスキンケアとして、例えばマッサージや保湿などが挙げられるがこれらに限定されるものではない。 In a further aspect of the present invention, the present invention also relates to a method for improving skin texture by increasing oxytalan fibers. Since the present inventors have discovered that oxytalan fibers in the skin epidermis are involved in the formation of skin texture, it has been found that increasing oxytalan fibers is important for improving the texture. Therefore, the skin texture can be improved by administration of a drug that increases oxytalan fibers in the epithelium or skin care. The improvement of the texture can be done for cosmetic, therapeutic and preventive purposes. Examples of such skin care include, but are not limited to, massage and moisturizing.
 本発明において肌理とは、皮膚の表面において、皮丘と皮溝により形成される表面形態のことをいう。肌理を構成する皮丘部は、皮溝により取り囲まれており、多くは三角形の形状をとるが、多角形の形状をとるものもある。肌理がよい状態とは、形の整った細かい三角形状の皮丘や皮溝の数が多い状態を云い、加齢とともに、皮溝及び皮丘が不鮮明になり、皮溝の数や密度が減少し、皮溝の長さが増加する傾向を有し、このような状態を肌理が悪い状態という。本明細書に定義された皮丘密度グレードは、皮丘の細かさを表すため、皮丘密度グレードが大きくなるほど、その肌理がよいと判定される(図1)。本発明者らは、表皮に対して縦に走るオキシタラン線維が皮丘部の内側に多く存在する一方で、皮溝部の内部には存在していないということを発見し、皮丘部の盛り上りが上皮内で縦に走るオキシタラン線維によりもたらされるという結論にいたった。皮丘部に密にかつ長いオキシタラン線維が存在する一方で、皮溝部にオキシタラン線維が存在しないことにより、皮溝が深くなり肌理状態が優れたものとなる。皮丘部のオキシタラン線維の密度や長さが減少することで、皮溝が浅くなり、皮溝と皮丘との境界が不鮮明になり、肌理が悪化する。したがって、単位長さあたりのオキシタランの線維長を計測することにより、肌理状態を評価することが可能になる。 In the present invention, the term “texture” refers to a surface form formed by a cuticle and a skin groove on the surface of skin. The skin hill part constituting the texture is surrounded by a skin groove, and many take a triangular shape, but some take a polygonal shape. A well-textured state refers to a state where the number of fine triangular cuticles and crevices that are well-formed is large, and the number and density of the crevice decreases with age as the crevice and cuticles become blurred. However, the length of the crevice tends to increase, and such a state is called a bad state. Since the hide density density grade defined in this specification represents the fineness of the hide, the larger the hide density density grade, the better the texture (FIG. 1). The present inventors have discovered that many oxytalan fibers running vertically to the epidermis are present inside the dermis, but not inside the sulcus, and the swell of the dermis is raised. It was concluded that is caused by oxytalan fibers running longitudinally in the epithelium. While dense and long oxytalan fibers are present in the cuticle part, and no oxytalan fibers are present in the skin groove part, the skin groove is deepened and the texture state is excellent. By reducing the density and length of the oxytalan fibers in the cuticle, the crevice becomes shallow, the boundary between the crevice and the cuticle becomes blurred, and the texture deteriorates. Therefore, it is possible to evaluate the texture state by measuring the fiber length of oxytalan per unit length.
 単位長さあたりの延べオキシタラン線維長を計測する皮膚の部位としては任意の部位が使用することができるが、特に頬、額などの顔の皮膚、手の甲や腕の皮膚が好ましい。例えば腕の皮膚の切片が用いられる。さらには、ダイエット手術で得られた余剰皮膚の断片を用いることもできる。この場合、腹部の皮膚について単位長さあたりの延べオキシタラン線維長が計測される。 Any site can be used as the site of the skin for measuring the total oxytalan fiber length per unit length, but the skin of the face such as the cheeks and the forehead, the back of the hand, and the skin of the hand are particularly preferable. For example, a slice of arm skin is used. Furthermore, a surplus skin fragment obtained by diet surgery can also be used. In this case, the total oxytalan fiber length per unit length is measured for the abdominal skin.
 皮膚切片の単位長さあたりの延べオキシタラン線維長の計測は、オキシタラン線維が判別できる様に皮膚切片を染色した後に行われる。皮膚切片の染色は、オキシタラン線維を識別できれば任意の方法であってもよい。例えば弾性線維を染色することができるエラスチカワンギーソン(ワイゲルト)染色が行われ、オキシタラン線維はワイゲルト液によって紫黒色に染色される。皮膚切片において、オキシタラン線維は、表皮面に対して垂直に走行しており、特に皮丘部において多く存在する(図2及び図3)。 Measurement of the total oxytalan fiber length per unit length of the skin section is performed after the skin section is stained so that the oxytalan fiber can be identified. The skin section may be stained by any method as long as oxytalan fibers can be identified. For example, Elastica Wangyson (Weigert) staining, which can stain elastic fibers, is performed, and oxytalan fibers are stained purple-black with Weigert's solution. In the skin section, the oxytalan fibers run perpendicular to the epidermis surface, and a large amount exists particularly in the cuticle (FIGS. 2 and 3).
 皮膚切片の染色画像をCCDカメラで取り込み、オキシタラン線維をコンピューターソフト(Win Roof)でトレースし、表皮1mmあたりの全トレース長を合計することにより、表皮単位長さあたりの延べオキシタラン線維長として測定することができる。 The stained image of the skin section is captured with a CCD camera, the oxytalan fibers are traced with computer software (Win Roof), and the total trace length per 1 mm of the epidermis is summed to measure the total oxytalan fiber length per unit length of the epidermis. be able to.
 「オキシタラン線維」とは、生体の結合組織における力学的強度を作り出す線維成分であり、弾性系線維のひとつである。弾性系線維は特に機械的圧力の加わる臓器や組織、例えば皮膚、血管、肺、靱帯などに豊富に認められる。弾性系線維は、エラスチンとミクロフィブリルタンパク質から構成されており、エラスチンの構成比により、弾性線維、エラウニン線維、オキシタラン線維の三種類に区分されている。オキシタラン線維はこれらの中で、エラスチン線維含有量が少なく、ミクロフィブリルタンパク質が密に束を形成したものである。組織中においては、歯を支える歯根膜や、皮膚では表皮面と垂直に走行する表皮直下の線維として存在することが報告されている(非特許文献2)。 “Oxytalan fiber” is a fiber component that creates mechanical strength in the connective tissue of a living body, and is one of elastic fibers. Elastic fibers are particularly abundant in organs and tissues subjected to mechanical pressure, such as skin, blood vessels, lungs, and ligaments. Elastic fibers are composed of elastin and microfibril protein, and are classified into three types according to the composition ratio of elastin: elastic fiber, elaurin fiber, and oxytalan fiber. Among these, oxytalan fibers are those in which the content of elastin fibers is low and the microfibril protein forms a dense bundle. In tissues, it has been reported that they exist as periodontal ligaments that support teeth and as fibers directly under the epidermis that run perpendicular to the epidermis surface in the skin (Non-patent Document 2).
 「皮丘密度グレード」は、皮丘の細かさの指標である。肌理の状態を悪い、やや悪い、普通、及び良いの4つの群に分け、それぞれの代表的な画像を図1に挙げ、それぞれを皮丘密度グレード1~4と定義する。被験者の皮膚の肌理画像を比較することにより、被験者の皮膚における皮丘密度グレードを決定することができる。
 具体的には、肌理の拡大画像に見慣れた熟練研究者複数名が、評価対象とする肌理画像群をこの皮丘密度グレードと比較し、一番近い皮丘の細かさを持つと視感的に感じられるグレード番号をそれぞれの肌理画像について選出する。このとき各肌理画像の由来被験者の年齢等の属性は、評価研究者、試験管理研究者双方に一切伏せることで、ダブルブラインドの試験とする。各肌理画像について得られた複数研究者からの皮丘密度グレードの平均値を算出することで、当該肌理画像の皮丘密度グレードとする。
 肌理状態と皮丘密度グレードは密接な関係を有していることから、皮丘密度グレード1~2に該当すると判定された場合、肌理状態が悪く、皮丘密度グレード2~3に該当すると判定された場合、肌理状態は普通であり、そして皮丘密度グレード3~4に該当すると判定された場合、肌理状態が良いと判定することができる。
“Dune density grade” is an indicator of the fineness of the hide. The texture is divided into four groups: bad, slightly bad, normal, and good, and representative images of each are listed in FIG. By comparing the skin texture images of the subject's skin, the hill density grade in the subject's skin can be determined.
Specifically, several experienced researchers familiar with the enlarged image of the texture compare the texture image group to be evaluated with this dendrite density grade, and have the fineness of the nearest dend. The grade number that can be felt is selected for each texture image. At this time, attributes such as age of the subject of each texture image are completely hidden by both the evaluation researcher and the test management researcher, so that a double blind test is performed. By calculating the average value of the hill density grades from a plurality of researchers obtained for each texture image, the skin density grade of the texture image is obtained.
Since the skin condition and the dermis density grade are closely related, if it is judged that it falls under the hill density grade 1-2, it is judged that the skin condition is bad and falls within the hill density grade 2-3. If it is determined that the texture state is normal, and it is determined that it corresponds to the hill density grade 3 to 4, it can be determined that the texture state is good.
 本明細書において使用される「投与」という語句には、経皮投与、経口投与、皮内投与、皮下投与、筋肉内投与、静脈内投与、腹腔内投与などが含まれるが、これらに限られるものではない。好ましくは、薬剤は、経皮投与、皮下投与、又は皮内投与により投与される。 The term “administration” as used herein includes, but is not limited to, transdermal administration, oral administration, intradermal administration, subcutaneous administration, intramuscular administration, intravenous administration, intraperitoneal administration, and the like. It is not a thing. Preferably, the medicament is administered by transdermal administration, subcutaneous administration, or intradermal administration.
エラスチカワンギーソン(ワイゲルト)染色
 ダイエット手術により得られた腹部の余剰皮膚断片について、常法に従い皮膚の凍結切片を作成し、10%中性緩衝ホルマリン液で組織を固定後、PBSで2回洗浄し、ワイゲルトレゾルシンフクシン染色液(武藤化学No.4032)に40分以上浸漬した。次に100%エタノールに短時間3回浸漬した後に、10分間水洗した。組織切片を水系包埋し、光学顕微鏡下で観察した。オキシタラン線維を含む弾性系線維は紫黒色に染色された(図2及び図3)。
For the surplus skin fragment of the abdomen obtained by Elastica wanggieson (Weigert) staining diet operation, a frozen section of the skin was prepared according to a conventional method, the tissue was fixed with 10% neutral buffered formalin solution, and then twice with PBS It was washed and immersed in Weiger tresol synthesize fuchsin staining solution (Mudo Chemical No. 4032) for 40 minutes or more. Next, it was immersed in 100% ethanol for a short time three times and then washed with water for 10 minutes. Tissue sections were embedded in water and observed under an optical microscope. Elastic fibers including oxytalan fibers were stained purple-black (FIGS. 2 and 3).
オキシタラン線維長の測定
 上記エラスチカワンギーソン(ワイゲルト)染色の染色画像をCCDカメラで取り込み、表皮面と垂直に走行する線維(オキシタラン線維)をコンピューターソフト(Win Roof(登録商標))を用いてトレースし、表皮1mmあたりの全トレース長を合計し、単位長さあたりの延べオキシタラン線維長とした(図4)。
Measurement of Oxytalan Fiber Length The above-mentioned stained image of Elastica Wanghisson (Weigert) staining is captured with a CCD camera, and fibers (oxytalan fibers) that run perpendicular to the epidermis surface are used with computer software (Win Roof (registered trademark)). The total trace length per 1 mm of the epidermis was totaled to obtain the total oxytalan fiber length per unit length (FIG. 4).
オキシタラン線維長と皮丘密度グレードとの相関性
 図1の肌理画像をそれぞれ皮丘密度グレード1~4と定義し、肌理の拡大画像に見慣れた熟練研究者4名が、評価対象とする肌理画像群をこの図1の画像と比較し、一番近い皮丘の細かさを持つと視感的に感じられるグレード番号をそれぞれの肌理画像について選出した。このとき各肌理画像の由来被験者の年齢等の属性は、評価研究者、試験管理研究者双方に一切伏せることで、ダブルブラインドの試験とし、各肌理画像について得られた複数研究者からの皮丘密度グレードの平均値を算出することで、当該肌理画像の皮丘密度グレードとした。
Correlation between Oxytalan Fiber Length and Peel Density Grade The texture image in Fig. 1 is defined as skin mound density grade 1 to 4 respectively, and four skilled researchers familiar with the enlarged texture image are the texture images to be evaluated. The group was compared with the image of FIG. 1, and a grade number that was visually felt as having the fineness of the nearest skin was selected for each texture image. At this time, the attributes such as age of the subject of each texture image are hidden by both the evaluation researcher and the test management researcher to make a double blind test, and the skins from multiple researchers obtained for each texture image By calculating the average value of the density grades, it was set as the hill density grade of the texture image.
 こうして得られた皮丘密度グレードと、単位長さあたりの延べオキシタラン線維長との関係は以下の表1のとおりであった。皮丘密度グレードに対して単位長さあたりの延べオキシタラン線維長をプロットして図5を得た。ピアソンの相関係数は0.54となり、皮丘密度グレードと単位長さあたりの延べオキシタラン線維長との間に相関が見られた。
Figure JPOXMLDOC01-appb-T000001
 皮丘密度グレードは、皮丘の細かさの指標であり、肌理と密接な関わりを有することから、皮膚のオキシタラン線維を指標として肌理を評価することができる。
Table 1 below shows the relationship between the bark density grade thus obtained and the total oxytalan fiber length per unit length. FIG. 5 was obtained by plotting the total oxytalan fiber length per unit length against the bark density grade. Pearson's correlation coefficient was 0.54, indicating a correlation between the dermis density grade and the total oxytalan fiber length per unit length.
Figure JPOXMLDOC01-appb-T000001
The skin density grade is an index of the fineness of the skin, and since it has a close relationship with the texture, the texture can be evaluated using the oxytalan fibers of the skin as an index.

Claims (4)

  1.  皮膚切片の単位長さあたりの延べオキシタラン線維長を計測することによる、美容目的で行われる肌理評価方法。 A texture evaluation method performed for cosmetic purposes by measuring the total oxytalan fiber length per unit length of a skin section.
  2.  計測した単位長さあたりの延べオキシタラン線維長を、肌理状態を表す単位長さあたりの延べオキシタラン線維長についての指標と比較する工程をさらに含む、請求項1に記載の肌理評価方法。 2. The texture evaluation method according to claim 1, further comprising a step of comparing the measured total oxytalan fiber length per unit length with an index of the total oxytalan fiber length per unit length representing the texture state.
  3.  候補薬剤の投与の前後において、皮膚切片の単位長さあたりの延べオキシタラン線維長を計測することによる、皮膚の肌理改善薬のスクリーニング方法。 A screening method for a skin texture-improving drug by measuring the total oxytalan fiber length per unit length of a skin section before and after administration of a candidate drug.
  4.  オキシタラン線維を増加させる薬剤を投与することによる皮膚の肌理改善方法。 A method of improving skin texture by administering a drug that increases oxytalan fibers.
PCT/JP2011/077397 2010-11-29 2011-11-28 Method for evaluating texture using oxytalan fibers as index WO2012073892A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010-265082 2010-11-29
JP2010265082A JP2012117827A (en) 2010-11-29 2010-11-29 Method for evaluating texture using oxytalan fiber as index

Publications (1)

Publication Number Publication Date
WO2012073892A1 true WO2012073892A1 (en) 2012-06-07

Family

ID=46171824

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2011/077397 WO2012073892A1 (en) 2010-11-29 2011-11-28 Method for evaluating texture using oxytalan fibers as index

Country Status (2)

Country Link
JP (1) JP2012117827A (en)
WO (1) WO2012073892A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103654724B (en) * 2012-09-04 2016-06-22 宝丽化成工业有限公司 Differential method based on the skin condition that filamentary structure is analyzed

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258900A (en) * 1985-02-14 1988-10-26 ポリデツクス フア−マス−テイカルズ,リミテツド Cosmetics preparation containing novel elastin derivative
JP2000154132A (en) * 1998-11-19 2000-06-06 Shiseido Co Ltd Antiaging agent
JP2003507400A (en) * 1999-08-20 2003-02-25 ハワード ムラード Pharmaceutical compositions and methods for reducing the appearance of cellulite
JP2003113068A (en) * 2001-08-02 2003-04-18 Maruzen Pharmaceut Co Ltd Skin cosmetic
JP2009510155A (en) * 2005-10-04 2009-03-12 エルブイエムエイチ レシェルシェ A cosmetic composition having an anti-aging activity, in particular, comprising an extract of plant Aframum angstiphorium or longoza

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258900A (en) * 1985-02-14 1988-10-26 ポリデツクス フア−マス−テイカルズ,リミテツド Cosmetics preparation containing novel elastin derivative
JP2000154132A (en) * 1998-11-19 2000-06-06 Shiseido Co Ltd Antiaging agent
JP2003507400A (en) * 1999-08-20 2003-02-25 ハワード ムラード Pharmaceutical compositions and methods for reducing the appearance of cellulite
JP2003113068A (en) * 2001-08-02 2003-04-18 Maruzen Pharmaceut Co Ltd Skin cosmetic
JP2009510155A (en) * 2005-10-04 2009-03-12 エルブイエムエイチ レシェルシェ A cosmetic composition having an anti-aging activity, in particular, comprising an extract of plant Aframum angstiphorium or longoza

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUNIKA AKAGI ET AL.: "Shiwa Bogyozai to Shigaisen Bogyozai no Kaihatsu ni Hitsuyo na Bio Hyoka Gijutsu Menu", BIOINDUSTRY, vol. 20, no. 5, 12 May 2003 (2003-05-12), pages 47 - 57 *

Also Published As

Publication number Publication date
JP2012117827A (en) 2012-06-21

Similar Documents

Publication Publication Date Title
de Berker et al. Science of the nail apparatus
Hariri et al. Effects of structural orientation of enamel and dentine on light attenuation and local refractive index: an optical coherence tomography study
Ishibashi et al. Swept-source optical coherence tomography as a new tool to evaluate defects of resin-based composite restorations
Contaldo et al. In vivo characterization of healthy oral mucosa by reflectance confocal microscopy: a translational research for optical biopsy
Hashmi et al. Characterising the biophysical properties of normal and hyperkeratotic foot skin
Agero et al. In vivo reflectance confocal microscopy of mycosis fungoides: a preliminary study
Dias et al. Age estimation from dental cementum incremental lines and periodontal disease
TW201430331A (en) Optical system for evaluating concentration and distribution of skin parameter and method thereof
Czekalla et al. Impact of body site, age, and gender on the collagen/elastin index by noninvasive in vivo vertical two-photon microscopy
JP2012161371A (en) Skin texture evaluation method by checking viscoelasticity on skin surface
JP2024054325A (en) Estimation method of hair, facial properties, etc. using stratum corneum cell properties of scalp skin
Tancrède‐Bohin et al. Non‐invasive short‐term assessment of retinoids effects on human skin in vivo using multiphoton microscopy
Just et al. In vivo observation of papillae of the human tongue using confocal laser scanning microscopy
Kawałkiewicz et al. Instrumental diagnosis of facial skin—A necessity or a pretreatment recommendation in esthetic medicine
Baldeweck et al. In vivo multiphoton microscopy associated to 3D image processing for human skin characterization
JP2020046200A (en) Skin condition identification method
WO2012073892A1 (en) Method for evaluating texture using oxytalan fibers as index
JP4176882B2 (en) Method for estimating skin age
JP2012202969A (en) Skin microrelief evaluation method by measuring contracted state of horny layer
Guarrera Additional methods for diagnosing alopecia and appraising their severity
JP2010148548A (en) Method of predicting wrinkle
JP6207926B2 (en) Body function estimation method
Gerdsen et al. Congenital smooth muscle hamartoma of the skin: clinical classification.
JP2007263655A (en) Skin judgement method by means of congo red
Kabakci et al. Morphometric analysis of the effects of high molecular weight sodium hyaluronate and amino acids mixture on face rejuvenation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11844398

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11844398

Country of ref document: EP

Kind code of ref document: A1